Cosmos Holdings Inc. (COSM)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.2037 |
| Open | 0.2050 |
| Bid | 0.2050 x 800 |
| Ask | 0.2190 x 900 |
| Day's Range | 0.2050 - 0.2147 |
| 52 Week Range | 0.1700 - 6.0000 |
| Volume | |
| Avg. Volume | 1,602,715 |
| Market Cap | 5.325M |
| Beta (5Y Monthly) | 1.39 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.1110 |
| Earnings Date | May 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for COSM
Related Research
- Cosmos Holdings Inc.Daily – Vickers Top Buyers & Sellers for 09/13/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat19 days agoArgus Research
- ACCESSWIRE
Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp.
Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into a non-binding letter of intent (LOI) agreement to wholly acquire ZipDoctor Inc. from American International Holdings Corp (AMIH).
- ACCESSWIRE
Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe
Cosmos Health, Inc. ("Cosmos") (NASDAQ:COSM), a global healthcare group with proprietary lines of nutraceuticals and distributor of pharmaceuticals, branded generics, OTC medications and medical devices, today announced that it has entered into an agreement with Virax Biolabs (VRAX), to become the distributor of Monkeypox Virus Real-Time PCR Detection Kits.
- PR Newswire
Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.
Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, announced today that it has entered into a distribution agreement to market Monkeypox Virus Real-Time PCR Detection Kits with Cosmos Holdings Inc. (Nasdaq: COSM) ("Cosmos"), an international healthcare group headquartered in the United States and with subsidiaries in Greece and the United Kingdom. Pursuant to the agreement
